Dai Hashimoto Selected Research

Pneumothorax

3/2023	Clinical features of idiopathic pleuroparenchymal fibroelastosis with progressive phenotype showing a decline in forced vital capacity.
11/2022	Comparison of clinical utility between digital and analog drainage systems in patients with spontaneous pneumothorax.
1/2021	Erlotinib and bevacizumab in elderly patients ≥75 years old with non-small cell lung cancer harboring epidermal growth factor receptor mutations.
1/2021	Pneumothorax in Patients with Idiopathic Pleuroparenchymal Fibroelastosis: Incidence, Clinical Features, and Risk Factors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dai Hashimoto Research Topics

Disease

12	Idiopathic Pulmonary Fibrosis 02/2024 - 08/2010
9	Asthma (Bronchial Asthma) 01/2019 - 04/2012
8	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2024 - 11/2004
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2023 - 01/2020
7	Infections 10/2021 - 01/2005
5	Neoplasms (Cancer) 01/2023 - 06/2012
4	Pneumothorax 03/2023 - 01/2021
4	Idiopathic Interstitial Pneumonias 03/2021 - 05/2008
4	Inflammation (Inflammations) 01/2015 - 04/2012
3	Fibrosis (Cirrhosis) 05/2023 - 08/2010
3	Pneumonia (Pneumonitis) 01/2023 - 01/2021
3	Lung Neoplasms (Lung Cancer) 01/2022 - 11/2016
3	Vascular Diseases (Vascular Disease) 03/2021 - 06/2009
2	Weight Loss (Weight Reduction) 03/2023 - 01/2023
2	Lung Diseases (Lung Disease) 02/2023 - 01/2023
2	Hypersensitivity (Allergy) 03/2021 - 01/2021
2	Disease Progression 01/2021 - 01/2015
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2019 - 12/2008
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2015 - 10/2009
2	Sarcoidosis (Schaumann Disease) 01/2015 - 01/2005
2	Airway Obstruction (Choking) 09/2014 - 04/2013
2	Tuberculosis (Tuberculoses) 09/2008 - 04/2008
1	Autoimmune Diseases (Autoimmune Disease) 12/2023
1	Dermatomyositis (Dermatopolymyositis) 12/2023
1	Hemorrhage 05/2023
1	Invasive Pulmonary Aspergillosis 02/2023
1	Dyspnea (Shortness of Breath) 01/2023
1	Malnutrition (Nutritional Deficiencies) 01/2023
1	Bronchiolitis Obliterans Syndrome 01/2023
1	Hepatitis 01/2023
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022
1	Nontuberculous Mycobacterium Infections 10/2021
1	Proteinuria 01/2021
1	Nausea 01/2019
1	Vomiting 01/2019
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2019
1	Autoimmune Pancreatitis 01/2018
1	Respiratory Tract Diseases (Respiratory Tract Disease) 11/2016

Drug/Important Bio-Agent (IBA)

10	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2023 - 04/2012
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 04/2012
4	Proteins (Proteins, Gene)FDA Link 07/2023 - 08/2010
4	CollagenIBA 03/2021 - 06/2009
4	Formoterol Fumarate (Oxis)FDA Link 01/2019 - 06/2012
4	Budesonide (Pulmicort)FDA LinkGeneric 01/2019 - 06/2012
4	VaccinesIBA 11/2015 - 04/2008
3	CytokinesIBA 12/2023 - 01/2014
3	Immune Checkpoint InhibitorsIBA 08/2023 - 01/2023
3	Prednisolone (Predate)FDA LinkGeneric 01/2023 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2011
3	Polymyxin B (Aerosporin)FDA LinkGeneric 02/2015 - 05/2008
2	ErbB Receptors (EGF Receptor)IBA 02/2023 - 01/2021
2	LipidsIBA 01/2022 - 01/2005
2	NivolumabIBA 01/2022 - 01/2020
2	LigandsIBA 01/2020 - 06/2012
2	pirfenidoneIBA 11/2019 - 01/2014
2	Phenobarbital (Luminal)FDA Link 01/2019 - 12/2018
2	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 01/2019 - 10/2016
2	Interleukin-17 (Interleukin 17)IBA 01/2015 - 01/2014
2	Connective Tissue Growth FactorIBA 09/2014 - 11/2011
2	Fluticasone (Cutivate)FDA LinkGeneric 02/2014 - 06/2012
2	Salmeterol Xinafoate (Serevent)FDA Link 02/2014 - 06/2012
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2014 - 11/2004
2	EpitopesIBA 11/2011 - 10/2009
2	Therapeutic UsesIBA 01/2011 - 05/2008
1	SteroidsIBA 02/2024
1	Antiviral Agents (Antivirals)IBA 12/2023
1	Interferon LambdaIBA 12/2023
1	Interleukin-15 (Interleukin 15)IBA 08/2023
1	Interleukin-6 (Interleukin 6)IBA 08/2023
1	atezolizumabIBA 07/2023
1	HemosiderinIBA 05/2023
1	Oxygen (Dioxygen)IBA 03/2023
1	Tyrosine Kinase InhibitorsIBA 02/2023
1	Voriconazole (Vfend)FDA LinkGeneric 02/2023
1	pembrolizumabIBA 01/2023
1	Indicators and Reagents (Reagents)IBA 01/2023
1	CholesterolIBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 10/2021
1	AutoantibodiesIBA 10/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021
1	B7-H1 AntigenIBA 01/2020
1	Olanzapine (Zyprexa)FDA Link 01/2019
1	Rituximab (Mabthera)FDA Link 01/2019
1	AntiemeticsIBA 01/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019
1	vilanterolIBA 01/2019
1	fluticasone furoate FDA Link 01/2019
1	Carboplatin (JM8)FDA LinkGeneric 01/2019
1	Immunoglobulin G (IgG)IBA 01/2018

Therapy/Procedure

17	Therapeutics 02/2024 - 06/2009
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2019
2	Hemoperfusion 02/2015 - 01/2011
2	Nebulizers and Vaporizers (Inhaler) 02/2014 - 06/2012
1	Duration of Therapy 01/2023
1	Chest Tubes (Chest Tube) 11/2022
1	Immunotherapy 01/2020
1	Dry Powder Inhalers 01/2019
1	Length of Stay 11/2016